PerkinElmer Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
16
Price Target
$162.50
Consensus
Outperform
Upside
17.28%
Analysts
4
Stock Rating
16
Upside
17.28%
Analysts
4
Price Target
$162.50

PerkinElmer Stock Forecast and Price Target

According to four experts, who recently provided their 2023 price targets for PerkinElmer, the average price target is $162.50, with a high estimate of $178.00 and a low estimate of $140.00. That is a potential upside of approximately 17.28% from the last closing price of $138.56 on January, 2023. If you are not interested in PKI stock, you may be interested in its competitors.

$162.50

17.28% Upside

Outperform
Outperform

PerkinElmer Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's Price has grown from $72.67 to $228.68 – a 214.68% increase. In the following year, the 11 analysts surveyed believe that PerkinElmer's Fair Value will decrease by 36.71%, reaching $144.73. According to professionals, by 2030, PerkinElmer's Fair Value will have decreased by 11.99%, falling down to $201.26.

2023 Fair Value Forecast
$144.73
2024 Fair Value Forecast
$161.24
2025 Fair Value Forecast
$186.61
2026 Fair Value Forecast
$215.79
2027 Fair Value Forecast
$216.20
2028 Fair Value Forecast
$196.52
2029 Fair Value Forecast
$194.09
2030 Fair Value Forecast
$201.26
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
AVGO Stock Forecast Broadcom Outperform 9
$597.62 $654.63 10.27%
SIE Stock Forecast Siemens Outperform 6
145.02€ 156.55€ 6.88%
ISRG Stock Forecast Intuitive Surgical Inc Outperform 15
$254.68 $273.80 10.73%
MRK Stock Forecast MERCK Kommanditgesellschaft au... Outperform 10
185.90€ 209.03€ 12.96%
GE Stock Forecast General Electric Outperform 9
$81.96 $86.47 6.15%

PerkinElmer Revenue Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's Revenue has grown from $2.78B to $5.07B – a 82.40% increase. In the following year, the 10 analysts surveyed believe that PerkinElmer's Revenue will decrease by 9.78%, reaching $4.57B. Over the next eight years, the forecast is for Revenue to grow by 2.42%.

2023 Rev Forecast
$4.57B
2024 Rev Forecast
$4.91B
2025 Rev Forecast
$5.39B
2026 Rev Forecast
$5.30B
2027 Rev Forecast
$5.05B
2028 Rev Forecast
$5.01B
2029 Rev Forecast
$5.13B
2030 Rev Forecast
$5.19B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
BDX Stock Forecast Becton, Dickinson and Outperform 17
$245.84 $268.00 11.86%
EMR Stock Forecast Emerson Electric Outperform 10
$91.39 $104.16 14.89%
ETN Stock Forecast Eaton Corp PLC Outperform 10
$163.24 $168.41 5.98%

PerkinElmer Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's Dividend per Share has decreased from $0.28 to $0.28 – a 0.00% drop! The next year, 7 experts forecast that PerkinElmer's Dividend per Share will decrease by 0.00%, reaching $0.28. In 2030, professionals predict that PerkinElmer's Dividend per Share will decrease by 0.51%, reaching $0.28.

2023 DPS Forecast
$0.28
2024 DPS Forecast
$0.27
2025 DPS Forecast
$0.28
2026 DPS Forecast
$0.28
2027 DPS Forecast
$0.28
2028 DPS Forecast
$0.28
2029 DPS Forecast
$0.28
2030 DPS Forecast
$0.28
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
DSY Stock Forecast Dassault Systèmes Hold 18
35.09€ 39.34€ 15.42%
EW Stock Forecast Edwards Lifesciences Outperform 15
$82.12 $92.45 13.25%
A Stock Forecast Agilent Technologies Outperform 17
$154.55 $162.50 7.73%

PerkinElmer Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's Free Cash Flow has grown, rising from $217.79M to $1.31B – a growth of 501.89%. For the next year, 3 analysts project PerkinElmer's Free Cash Flow to drop by 33.21%, reaching $875.57M. By 2030, professionals believe that PerkinElmer's Free Cash Flow will decrease by 15.90%, reaching $1.10B – a concerning trend for the company.

2023 FCF Forecast
$0.88B
2024 FCF Forecast
$0.95B
2025 FCF Forecast
$1.06B
2026 FCF Forecast
$1.20B
2027 FCF Forecast
$1.08B
2028 FCF Forecast
$1.04B
2029 FCF Forecast
$1.05B
2030 FCF Forecast
$1.10B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
PH Stock Forecast Parker-Hannifin Outperform 16
$350.00 $338.22 -2.57%
LONN Stock Forecast Lonza Group Ltd Outperform 16
CHF457.90 CHF756.46 71.98%
RMD Stock Forecast ResMed Outperform 17
$224.60 $251.67 12.42%

PerkinElmer Net Income Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's Net Income has grown by 296.40%, rising from $237.93M to $943.16M. According to the 8 analysts polled, in the next year, PerkinElmer's Net Income will fall by 3.53%, reaching $909.85M. Over the next eight years, experts predict that PerkinElmer's Net Income will grow at a rate of 24.08%.

2023 NI Forecast
$0.91B
2024 NI Forecast
$1.01B
2025 NI Forecast
$1.16B
2026 NI Forecast
$1.27B
2027 NI Forecast
$1.13B
2028 NI Forecast
$1.10B
2029 NI Forecast
$1.12B
2030 NI Forecast
$1.17B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
IDXX Stock Forecast IDEXX Laboratories Inc Outperform 16
$482.41 $479.56 3.65%
7751 Stock Forecast Canon Hold 18
¥2.86k ¥0.00 16.95%
HOLX Stock Forecast Hologic Inc Outperform 8
$84.68 $79.86 -2.57%

PerkinElmer EBITDA Forecast for 2023 - 2025 - 2030

PerkinElmer's EBITDA has grown In the last three years, rising from $518.76M to $1.87B – a growth of 260.16%. According to 8 prominent analysts, PerkinElmer's EBITDA will fall by 30.96% in the next year, reaching $1.29B. By 2030, professionals believe that PerkinElmer's EBITDA will decrease by 16.53%, reaching $1.56B – a concerning trend for the company.

2023 EBITDA Forecast
$1.29B
2024 EBITDA Forecast
$1.40B
2025 EBITDA Forecast
$1.61B
2026 EBITDA Forecast
$1.63B
2027 EBITDA Forecast
$1.51B
2028 EBITDA Forecast
$1.48B
2029 EBITDA Forecast
$1.52B
2030 EBITDA Forecast
$1.56B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
STE Stock Forecast STERIS Outperform 13
$219.03 $227.00 0.44%
DGX Stock Forecast Quest Diagnostics Hold 10
$142.81 $147.77 1.18%
ERF Stock Forecast Eurofins Scientific Hold 18
66.16€ 0.00€ 58.71%

PerkinElmer EBIT Forecast for 2023 - 2025 - 2030

PerkinElmer's EBIT has seen impressive growth In the last three years, rising from $338.17M to $1.51B – a growth of 346.63%. In the following year, 9 experts forecast PerkinElmer's EBIT will decrease by 19.55%, to $1.22B. For the next eight years, the forecast is for EBIT to grow by 4.34%.

2023 EBIT Forecast
$1.22B
2024 EBIT Forecast
$1.34B
2025 EBIT Forecast
$1.49B
2026 EBIT Forecast
$1.58B
2027 EBIT Forecast
$1.75B
2028 EBIT Forecast
$1.60B
2029 EBIT Forecast
$1.57B
2030 EBIT Forecast
$1.58B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TECH Stock Forecast Bio-Techne Buy 16
$79.16 $485.91 31.06%
BIO Stock Forecast Bio-Rad Laboratories Buy 16
$470.88 $588.75 23.70%
CSL Stock Forecast Carlisle Companies Outperform 18
$250.48 $348.33 39.73%

PerkinElmer EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, PerkinElmer's EPS has grown from $3.61 to $11.36 – a 214.68% increase. In the following year, the 11 analysts surveyed believe that PerkinElmer's EPS will decrease by 36.71%, reaching $7.19. According to professionals, by 2030, PerkinElmer's EPS will have decreased by 11.99%, falling down to $10.00.

2023 EPS Forecast
$7.19
2024 EPS Forecast
$8.01
2025 EPS Forecast
$9.27
2026 EPS Forecast
$10.72
2027 EPS Forecast
$10.74
2028 EPS Forecast
$9.76
2029 EPS Forecast
$9.64
2030 EPS Forecast
$10.00
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
QGEN Stock Forecast QIAGEN N.V. Outperform 15
$49.54 $0.00 11.02%
HSIC Stock Forecast Henry Schein Inc Hold 7
$86.76 $82.67 -4.33%
7701 Stock Forecast Shimadzu Outperform 18
¥3.65k ¥0.00 52.05%